期刊文献+

富含半胱氨酸蛋白61在球囊损伤大鼠腹主动脉中的表达变化 被引量:6

Cysteine-Rich 61 Expression in Rats Abdominal Artery After Balloon Injury
下载PDF
导出
摘要 目的观察大鼠腹主动脉球囊损伤后富含半胱氨酸蛋白61表达的变化。方法对球囊损伤后不同时间段的大鼠腹主动脉标本采用组织形态学观察内膜增生,采用免疫组织化学、逆转录聚合酶链反应、免疫蛋白印记分析检测富含半胱氨酸蛋白61的表达。结果球囊损伤后可见新生内膜在术后7天出现,术后14天明显增厚,术后28天内膜继续增生,形成的新生内膜厚度不均,较假手术组明显增厚(P<0.01)。球囊损伤后7天、14天采用免疫组织化学、逆转录聚合酶链反应、蛋白印记分析检测富含半胱氨酸蛋白61的表达均明显增强,与假手术组比较差异有显著性(P<0.01)。28天时与假手术组比较差异没有显著性(P>0.05)。结论球囊损伤后富含半胱氨酸蛋白61的表达明显增强,提示富含半胱氨酸蛋白61可能在球囊损伤后内膜增生过程中起重要作用。 Aim To investigate the change of Cysteine-rich 61 in rats abdominal artery injured by balloon. Methotis Forty-eight Wistar male rats were studied. Balloon injury was conducted in abdominal artery respecfively. Rats were killed at different time points and abdominal artery were collected in time. Intimal hyperplasia was studied by histological morphology method. The expression of tissue Cysteine-rich 61 was determined by immunoistochemieally, reverse transcription poly- merase chain reaction and western-blot. Results Intimal hyperplasia was present at 7th day after balloon injury, became more obvious at 14th day and in progression at 28th day. No change was observed in control group. The expression of Cysteine-rich 61 increased significantly at 7th day and 14th day after balloon injury, and it was significantly different between injury group and control group(P〈0.01}. The expression of Cysteine-rich 61 was not significantly different between injury group and control group at 28th day (P〉0.05). Conclusions Cysteinc-rich 61 expressed stronger in injury group than that in control group, which indicated that Cysteine-rich 61 may play an important role in intimal hyperplasia caused by balloon injury.
出处 《中国动脉硬化杂志》 CAS CSCD 2006年第11期971-974,共4页 Chinese Journal of Arteriosclerosis
关键词 内科学 富含半胱氨酸蛋白61 免疫组织化学 逆转录聚合酶链反应 球囊损伤 内膜增生 大鼠 Cysteine-Rich 61 Balloon Injury Intimal Hyperplasia Rats Abdominal Artery
  • 相关文献

参考文献15

  • 1Ross R.The pathogensis of atherosclerosis:a perspective for the 1990s[J].Nature,1993,362:801-809
  • 2王伟,谭孝厚,庄汉屏.结合肝素的表皮样生长因子及血小板源生长因子A在动脉粥样硬化血管壁中的表达[J].中国动脉硬化杂志,2002,10(3):221-224. 被引量:3
  • 3金炜,董维平,杨红,何奔,孙宝贵.转化生长因子β_1在动脉粥样硬化形成中的作用及机制研究[J].中国药理学通报,2003,19(6):650-653. 被引量:16
  • 4苏海霞,盛净,刘德莉,夏万尧,成静,陈朝婷.胰岛素样生长因子1受体抗体对大鼠血管平滑肌细胞增殖的影响[J].中国动脉硬化杂志,2006,14(2):137-139. 被引量:3
  • 5O'Brien TP,Yang GP,Sanders L,Lau LF.Expression of cyr61:a growth factor-inducible immediate-early gene[J].Mol Cell Biol,1990,10 (7):3 569-577
  • 6Tatiana M,Grzeszkiewicz,Volkhard Lindner,Ningyu Chen,Stephen CT Lam,Lester F,et al.The angiogenic factor cysteine-rich 61 (CYR61,CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin a6β1 and cell surface heparan sulfate proteoglycans[J].Endocrinology,2002,143 (4):1 441-450
  • 7Bork P.The modular architecture of a new family of growth regulators related to connective tissue growth factor[J].FEBS Lett,1993,327 (2):125-130
  • 8Jay P,Berge-Lefranc JL,Marsollier C,Mejean C,Taviaux S,Berta P.The human growth factor-inducible immediate early gene,CYR61,maps to chromosome 1p.Oncogene[J].1997,14 (14):1 753-757
  • 9Kireeva ML,MO FE,Yang GP,Lau LF.Cyr61,a product of a growth factor-inducible immediate early gene,promotes cell proliferation,migration,and adhesion[J].Mol Cell Biol,1996,16 (4):1 326-334
  • 10Kireeva ML,Latinkic BV,Kolesnikova TV,Chen CC,Yang Gp,Abler AS,et al.Cyr61 and Fisp12 are both ECM-associated signaling molecules:activities,metabolism,and localization during development[J].Exp Cell Res,1997,233 (1):63-77

二级参考文献29

  • 1王旭开,杨成明,刘光耀,谯怡然.复合胶元酶法分离人血管平滑肌细胞的新方法[J].第三军医大学学报,1993,15(4):357-360. 被引量:13
  • 2庞荣清,潘兴华,龙沛然,覃敏,吴亚玲.灯盏花素对兔血管平滑肌细胞增殖的影响[J].中国动脉硬化杂志,2004,12(4):395-398. 被引量:15
  • 3苏海霞,盛净.大鼠和兔颈动脉再狭窄模型比较[J].中国动脉硬化杂志,2005,13(3):332-334. 被引量:7
  • 4张均田.现代药理实验方法,第一版[M].北京:北京医科大学协和医科大学联合出版社,1998,1.266-268.
  • 5[1]Zhang WD, Bai HZ, Sawa Y, et al. J Vase Surg, 1999; 30 (1): 169~183
  • 6[2]Weister-Evans MC, Quinn BE, Burkard MR, et al. J Cell Physiol, 2000; 182(1): 12~23
  • 7[3]Zibara K, Bourdillon MC, Chignier E, et al. Arterioscler Thromb Vasc Biol, 1999; 19(7): 1650~1657
  • 8[4]Watanabe N, Kurabayashi M, Shimomura Y, et al. Circ Res, 1999; 85(2): 182~191
  • 9[5]Neylon CB, Lang RJ, Fu Y, et al. Circ Res, 1999; 85(9): e33~e43
  • 10[6]Lehoux S, Tedgui A. Hypertension, 1998; 32(2): 338~345

共引文献24

同被引文献48

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部